AMED
Income statement / Annual
Last year (2023), Amedisys, Inc.'s total revenue was $2.24 B,
an increase of 0.59% from the previous year.
In 2023, Amedisys, Inc.'s net income was -$9.75 M.
See Amedisys, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$2.24 B
|
$2.22 B
|
$2.21 B
|
$2.07 B
|
$1.96 B
|
$1.66 B
|
$1.53 B
|
$1.44 B
|
$1.28 B
|
$1.20 B
|
| Cost of Revenue |
$1.78 B |
$1.26 B |
$1.23 B |
$1.19 B |
$1.15 B |
$992.86 M |
$900.73 M |
$833.06 M |
$725.92 M |
$691.06 M |
| Gross Profit |
$457.08 M |
$962.77 M |
$980.76 M |
$886.15 M |
$805.30 M |
$669.72 M |
$632.95 M |
$604.40 M |
$554.63 M |
$513.49 M |
| Gross Profit Ratio |
0.2 |
0.43 |
0.44 |
0.43 |
0.41 |
0.4 |
0.41 |
0.42 |
0.43 |
0.43 |
| Research and Development
Expenses |
$3.80 M
|
$3.00 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative
Expenses |
$264.01 M
|
$754.06 M
|
$711.24 M
|
$668.30 M
|
$607.93 M
|
$501.31 M
|
$482.21 M
|
$503.43 M
|
$452.44 M
|
$441.74 M
|
| Selling & Marketing
Expenses |
$516.05 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$780.06 M
|
$754.06 M
|
$711.24 M
|
$668.30 M
|
$607.93 M
|
$501.31 M
|
$482.21 M
|
$503.43 M
|
$452.44 M
|
$441.74 M
|
| Other Expenses |
$50.62 M |
$24.94 M |
$17.60 M |
-$5.57 M |
$18.43 M |
$3.24 M |
$3.77 M |
$3.73 M |
$9.75 M |
$2.06 M |
| Operating Expenses |
$834.48 M |
$778.99 M |
$728.84 M |
$662.73 M |
$626.35 M |
$514.57 M |
$524.40 M |
$542.63 M |
$486.52 M |
$486.34 M |
| Cost And Expenses |
$2.08 B |
$2.04 B |
$1.96 B |
$1.85 B |
$1.78 B |
$1.51 B |
$1.43 B |
$1.38 B |
$1.21 B |
$1.18 B |
| Interest Income |
$3.27 M |
$178,000.00 |
$49,000.00 |
$292,000.00 |
$78,000.00 |
$278,000.00 |
$158,000.00 |
$75,000.00 |
$71,000.00 |
$94,000.00 |
| Interest Expense |
$31.27 M |
$22.23 M |
$9.53 M |
$11.04 M |
$14.52 M |
$7.37 M |
$5.03 M |
$5.16 M |
$10.78 M |
$8.22 M |
| Depreciation &
Amortization |
$23.85 M
|
$24.94 M
|
$30.90 M
|
$28.80 M
|
$18.43 M
|
$13.26 M
|
$17.12 M
|
$19.68 M
|
$20.04 M
|
$28.31 M
|
| EBITDA |
$216.91 M
|
$207.41 M
|
$320.66 M
|
$250.66 M
|
$203.35 M
|
$179.62 M
|
$128.28 M
|
$81.45 M
|
$88.14 M
|
$57.50 M
|
| EBITDA Ratio |
0.1 |
0.12 |
0.15 |
0.14 |
0.12 |
0.11 |
0.09 |
0.06 |
0.08 |
0.05 |
| Operating Income Ratio
|
0.07
|
0.08
|
0.11
|
0.11
|
0.09
|
0.09
|
0.05
|
0.04
|
-0.01
|
0.02
|
| Total Other
Income/Expenses Net |
-$116.77 M
|
-$20.53 M
|
$28.32 M
|
-$8.45 M
|
-$7.06 M
|
$3.84 M
|
$2.28 M
|
$4.23 M
|
$8.86 M
|
-$3.07 M
|
| Income Before Tax |
$39.62 M |
$160.24 M |
$280.23 M |
$210.82 M |
$170.41 M |
$158.99 M |
$80.80 M |
$61.57 M |
-$308,000.00 |
$20.98 M |
| Income Before Tax Ratio
|
0.02
|
0.07
|
0.13
|
0.1
|
0.09
|
0.1
|
0.05
|
0.04
|
-0
|
0.02
|
| Income Tax Expense |
$50.56 M |
$42.55 M |
$70.07 M |
$25.64 M |
$42.50 M |
$38.86 M |
$50.12 M |
$23.94 M |
$2.00 M |
$7.67 M |
| Net Income |
-$9.75 M |
$118.61 M |
$209.07 M |
$183.61 M |
$126.83 M |
$119.35 M |
$30.30 M |
$37.26 M |
-$3.02 M |
$12.78 M |
| Net Income Ratio |
-0 |
0.05 |
0.09 |
0.09 |
0.06 |
0.07 |
0.02 |
0.03 |
-0 |
0.01 |
| EPS |
-0.3 |
3.65 |
6.41 |
5.64 |
3.95 |
3.64 |
0.9 |
1.12 |
-0.0915 |
0.39 |
| EPS Diluted |
-0.3 |
3.63 |
6.34 |
5.52 |
3.84 |
3.55 |
0.88 |
1.1 |
-0.0915 |
0.39 |
| Weighted Average Shares
Out |
$32.49 M
|
$32.52 M
|
$32.64 M
|
$32.56 M
|
$32.14 M
|
$32.79 M
|
$33.70 M
|
$33.20 M
|
$33.02 M
|
$32.30 M
|
| Weighted Average Shares
Out Diluted |
$32.60 M
|
$32.65 M
|
$32.97 M
|
$33.27 M
|
$32.99 M
|
$33.61 M
|
$34.30 M
|
$33.74 M
|
$33.02 M
|
$32.82 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
